Work

Outcome in patients with refractory high-risk neuroblastoma.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.10537

Authors: Amir Bari Siddiqui, Akosua Oppong, Cindy Yuan, Guimin Gao, Rochelle Bagatell, Katherine Berg, Elizabeth Sokol, Kyle MacQuarrie, Navin R. Pinto, Anurekha Gollapudi, Rajen Mody, Ian Wolfe, Suzanne Shusterman, Jennifer Foster, Valeria Smith, Susan Lerner Cohn, Ami Vijay Desai

Institutions: University of Chicago Medical Center, Children's Hospital of Philadelphia, University of Chicago, Lurie Children's Hospital, Seattle Children's Hospital, University of Michigan, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Texas Children's Hospital

Language: English

Topic: Neuroblastoma Research and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3032441097

Cites:

Cited by: 1

Related to: 10